Tag: Heart / Stroke-Related: High Cholesterol
Health, Economic Impact of CVD Preventive Services Varies
Highest health impact for hypertension screening and treatment, lowest for aspirin counseling
Achieving LDL-Particle Targets Deemed Cost-Effective
LDL-lowering therapy guided by LDL-P is cost-effective, with greater economic benefits over time
Similar Effects for PCSK9, HMGCR Variant-Mediated Lower LDL
Almost equivalent effects on cardiovascular events, diabetes per unit decrease in LDL-cholesterol level
Levels of Total, LDL Cholesterol Continue to Fall in the U.S.
Eliminating trans fats from the U.S. diet may be one factor in this healthy trend
AHA: Inclisiran Twice Yearly May Effectively Control Cholesterol
Injectable medication is a next-level PCSK9 inhibitor
AHA: Evolocumab Can Help Substantially Reduce LDL
Patients taking evolocumab and statins showed a reduction in arterial plaque volume
PCSK9, LDL-C Link Only Seen for Patients With Highest HbA1c
In patients with type 1 diabetes, correlation only seen for those in the highest tertile of HbA1c
Low and High HDL Tied to Increased Risk of Mortality
Study casts doubt on HDL as an independent cardiovascular disease risk factor
Child-Parent Screening for Hypercholesterolemia Feasible
Screening feasible in primary care at routine child immunization visits for children aged 1 to 2 years
Both Statin, Non-Statin Therapies Effective for Lowering LDL
Dietary changes, other meds, and even surgery can lower cardiovascular risk similarly to statins
